000 02397 a2200649 4500
005 20250513233802.0
264 0 _c20010517
008 200105s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0703976
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, C M
245 0 0 _aMitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cApr 2001
300 _a1531-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBenzoquinones
650 0 4 _aCalcium
_xpharmacology
650 0 4 _aDNA
_xbiosynthesis
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aEstrenes
_xpharmacology
650 0 4 _aFlavonoids
_xpharmacology
650 0 4 _aGenistein
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLactams, Macrocyclic
650 0 4 _aLipoproteins, LDL
_xpharmacology
650 0 4 _aMAP Kinase Signaling System
_xdrug effects
650 0 4 _aMitogen-Activated Protein Kinase 1
_xdrug effects
650 0 4 _aMitogen-Activated Protein Kinase 3
650 0 4 _aMitogen-Activated Protein Kinases
_xdrug effects
650 0 4 _aMitogens
_xpharmacology
650 0 4 _aMuscle, Smooth, Vascular
_xcytology
650 0 4 _aPertussis Toxin
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProtein Kinase C
_xantagonists & inhibitors
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins c-raf
_xmetabolism
650 0 4 _aPyrrolidinones
_xpharmacology
650 0 4 _aQuinones
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRifabutin
_xanalogs & derivatives
650 0 4 _aStaurosporine
_xpharmacology
650 0 4 _aVirulence Factors, Bordetella
_xpharmacology
650 0 4 _aras Proteins
_xmetabolism
700 1 _aChien, C S
700 1 _aHsiao, L D
700 1 _aPan, S L
700 1 _aWang, C C
700 1 _aChiu, C T
700 1 _aLin, C C
773 0 _tBritish journal of pharmacology
_gvol. 132
_gno. 7
_gp. 1531-41
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0703976
_zAvailable from publisher's website
999 _c11200568
_d11200568